SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-24-000539
Filing Date
2024-03-21
Accepted
2024-03-21 15:47:08
Documents
20
Period of Report
2024-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20240315.htm   iXBRL 8-K 27036
2 FORM OF CONVERTIBLE NOTE PURCHASE AGREEMENT DATED MARCH 15, 2024 axim_ex10z1.htm EX-10.1 15081
3 FORM OF VERSION 1 NOTE DATED MARCH 15, 2024 axim_ex10z2.htm EX-10.2 28060
4 FORM OF VERSION 2 NOTE DATED MARCH 15, 2024 axim_ex10z3.htm EX-10.3 28906
5 FORM OF VERSION 3 NOTE DATED MARCH 15, 2024 axim_ex10z4.htm EX-10.4 27806
6 FORM OF STOCK PURCHASE AGREEMENT DATED MARCH 15, 2024 axim_ex10z5.htm EX-10.5 11585
11 IMAGE axim8k_1.jpg GRAPHIC 4297
  Complete submission text file 0001096906-24-000539.txt   313100

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20240315_def.xml EX-101.DEF 1842
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20240315_lab.xml EX-101.LAB 20742
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20240315_pre.xml EX-101.PRE 13772
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20240315.xsd EX-101.SCH 2378
23 EXTRACTED XBRL INSTANCE DOCUMENT axim-20240315_htm.xml XML 2679
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 24771114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)